Australia's largest stock trading and investment forum Australia's #1 stock forum

AN1

Click for more information

0.00%

0.8¢ anagenics limited

PacificEdge update, page-5

First 5 Last

Share
Profile

Follow
mistag

218 Posts.

43

01/05/17

11:17

Post #: 24377103
Share

Originally posted by mightypirate ↑

I think page 3 of the investor update is referring to the following announcement from a fortnight ago:

Cxbladder Monitor Significantly Outperforms All Compared FDA Approved Urine Tests For Bladder Cancer; Enhancing The Standard Of Care For Bladder Cancer Patients (Click here)

This should provide Cellmid with further licensing fees in the next few years, particularly if CxBladder is being picked up as the de-facto standard test. In this context, I particularly like the first paragraph of page 2 in the Investor update:

This choice of words ('where', not 'if'), shows confidence, and with such outperformance of comparable tests, I can see why. While Pacific Edge is not Cellmid, the success of CxBladder shows how a single indication for midkine as a biomarker can generate revenue for Cellmid, where there are potentially many following, such as the recently mentioned mesothelioma.

It is nice to know too that Cellmid is invested in Pacific Edge with over a million shares.

Expand

Just to clarify, Cellmid sold those Pacific Edge shares on-market back in FY14. A pretty sound move given the subsequent decline in PEB's share price. Or perhaps a recognition of the long road ahead for getting CxBladder commercialised.

CDY Price at posting: 3.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

There are more pages in this discussion • 272 more messages in this thread...

First 5 Last

Add AN1 (ASX) to my watchlist